Zhigao Niu

Zhigao Niu

Company: Novo Nordisk

Job title: Innovation Lead & Senior Scientist

Seminars:

Industry Leaders Panel Discussion: Starting With End Goals in Mind – Defining Patient-Centric Peptide Drug Delivery & Formulations to Improve Patient Adherence & Patient Outcomes 9:00 am

Using patient population characteristics to define optimal and impactful peptide therapeutic formulation and modes of administration Considering age-appropriate formulations, drug dosing, ability to self-administer, disease characteristics, disease severity, patient experience of treatment and other factors Balancing unmet patient needs with commercial value and differentiation of peptide therapeutic product formulation and deliveryRead more

day: Day One

Exploring Solid & Liquid Formulations for Oral Peptide Delivery 2:00 pm

Optimizing SNAC-based peptide formulations to achieve higher bioavailability Demonstrating mechanistic understanding of the in vivo behaviours Sharing preclinical and clinical data in dogs and humans, and discussing translatability challengesRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.